UnitedHealth Group reported first-quarter earnings and revenue that exceeded analyst expectations, with adjusted EPS of $7.23 beating the $6.59 estimate and revenue of $111.7 billion surpassing the $109.44 billion forecast. The company raised its full-year 2026 adjusted earnings outlook to at least $18.25 per share, above the consensus of $17.87. While Optum Rx revenue grew 2% driven by specialty pharmacy, Optum Health revenue declined 3% due to lower value-based care membership. UnitedHealth's shares rose 8% in pre-market trading following the strong results and optimistic profit guidance.
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
